Rep. Norm Thurston — Voting Record

Bill

Number

H.B. 420 (2017GS)

Sponsor

Rep. Thurston, N.  (Thurston’s own bill)

Final action

House/ filed 3/9/2017

Outcome

Failed / filed without passage

Summary

What it does

• This bill:
• requires the Department of Health to study the importation of certain prescription drugs;
• specifies study requirements, including determining how the state may become certified to operate a prescription drug importation program;
• requires the department to consult with certain persons; and
• requires the department to report its findings and recommendations.

Every vote on this bill

Bill text

PRESCRIPTION DRUG IMPORTATION STUDY
GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Norman K Thurston
Senate Sponsor: 
____________
LONG TITLE
General Description:
This bill requires the Department of Health to study and report on prescription drug
importation.
Highlighted Provisions:
This bill:
▸ requires the Department of Health to study the importation of certain prescription
drugs;
▸ specifies study requirements, including determining how the state may become
certified to operate a prescription drug importation program;
▸ requires the department to consult with certain persons; and
▸ requires the department to report its findings and recommendations. 
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Uncodified Material Affected:
ENACTS UNCODIFIED MATERIAL
Be it enacted by the Legislature of the state of Utah:
Section 1. 
Prescription drug importation study.
(1) The Department of Health shall study how to gain approval for the state of Utah to
import certain prescription drugs from other countries for eventual consumption by Utah
consumers.
(2) In the study the department shall:
(a) determine how the state of Utah can become certified by the United States Secretary
of Health and Human Services to operate a prescription drug importation program;
(b) determine how to ensure that only drugs meeting United States Food and Drug
Administration safety, effectiveness, and other standards are imported by the state;
(c) identify prescription drugs with the highest potential for consumer savings through
importation;
(d) estimate potential consumer savings attributable to importation;
(e) determine with whom the state could contract to distribute imported drugs;
(f) determine how to limit the distribution of imported drugs to only Utahns who would
benefit most from the associated savings;
(g) consult with the Utah State Board of Pharmacy created in Section 
58-17b-201
,
representatives of the pharmaceutical industry, patient advocates, and others representing
persons who could be affected by importation; and
(h) propose amendments to the Utah Code to facilitate importation by the state.
(3) The department shall report the department's findings and recommendations to the
Health and Human Services Interim Committee before November 1, 2017.
Legislative Review Note
Office of Legislative Research and General Counsel